Abstract
Positive results in the RENAISSANCE Trial will establish oligometastatic gastric cancer as a real independent entity where total surgical treatment will become the standard of care.
Keywords:
RENAISSANCE Trial; curative treatment; gastric cancer; local treatment; oligometastatic.
MeSH terms
-
Cytoreduction Surgical Procedures
-
Humans
-
Hyperthermic Intraperitoneal Chemotherapy
-
Liver Neoplasms / diagnosis
-
Liver Neoplasms / mortality
-
Liver Neoplasms / secondary*
-
Liver Neoplasms / therapy
-
Lung Neoplasms / diagnosis
-
Lung Neoplasms / mortality
-
Lung Neoplasms / secondary*
-
Lung Neoplasms / therapy
-
Lymphatic Metastasis / diagnosis
-
Lymphatic Metastasis / pathology
-
Lymphatic Metastasis / therapy
-
Patient Selection
-
Peritoneal Neoplasms / diagnosis
-
Peritoneal Neoplasms / mortality
-
Peritoneal Neoplasms / secondary*
-
Peritoneal Neoplasms / therapy
-
Prognosis
-
Stomach Neoplasms / diagnosis
-
Stomach Neoplasms / mortality
-
Stomach Neoplasms / pathology*
-
Stomach Neoplasms / therapy
-
Survival Rate